Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
| Image |  |
|---|---|
| Description | scientific article published on 11 February 2014 |
| Author/s |
author: Edwin Bremer |
| Publication date | February 11, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |